|Tet-on systems for doxycycline-inducible gene expression|
A T Das, L Tenenbaum, B Berkhout
Current gene therapy 16 (3), 156-167, 2016
|Recombinant AAV‐mediated gene delivery to the central nervous system|
L Tenenbaum, A Chtarto, E Lehtonen, T Velu, J Brotchi, M Levivier
The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2004
|Evaluation of risks related to the use of adeno-associated virus-based vectors|
L Tenenbaum, E Lehtonen, PE Monahan
Current gene therapy 3 (6), 545-565, 2003
|Clinical potential of minocycline for neurodegenerative disorders|
D Blum, A Chtarto, L Tenenbaum, J Brotchi, M Levivier
Neurobiology of disease 17 (3), 359-366, 2004
|Rescue and sprouting of motoneurons following ventral root avulsion and reimplantation combined with intraspinal adeno-associated viral vector-mediated expression of glial cell …|
B Blits, TP Carlstedt, MJ Ruitenberg, F de Winter, WT Hermens, ...
Experimental neurology 189 (2), 303-316, 2004
|Characterization of a recombinant adeno-associated virus type 2 Reference Standard Material|
M Lock, S McGorray, A Auricchio, E Ayuso, EJ Beecham, V Blouin-Tavel, ...
Mary Ann Liebert, Inc. 140 Huguenot Street, 3rd Floor New Rochelle, NY 10801 USA, 2010
|Tetracycline-inducible transgene expression mediated by a single AAV vector|
A Chtarto, HU Bender, CO Hanemann, T Kemp, E Lehtonen, M Levivier, ...
Gene therapy 10 (1), 84-94, 2003
|Regulated viral BDNF delivery in combination with Schwann cells promotes axonal regeneration through capillary alginate hydrogels after spinal cord injury|
S Liu, B Sandner, T Schackel, LS Nicholson, A Chtarto, L Tenenbaum, ...
Acta Biomaterialia 60, 167-180, 2017
|Biosafety of recombinant adeno-associated virus vectors|
D J Dismuke, L Tenenbaum, R Jude Samulski
Current gene therapy 13 (6), 434-452, 2013
|Manufacturing and characterization of a recombinant adeno-associated virus type 8 reference standard material|
E Ayuso, V Blouin, M Lock, S Mcgorray, X Leon, MR Alvira, A Auricchio, ...
Human gene therapy 25 (11), 977-987, 2014
|MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation study in schizophrenia …|
D Dwir, B Giangreco, L Xin, L Tenenbaum, JH Cabungcal, P Steullet, ...
Molecular psychiatry 25 (11), 2889-2904, 2020
|Controlled delivery of glial cell line-derived neurotrophic factor by a single tetracycline-inducible AAV vector|
A Chtarto, X Yang, O Bockstael, C Melas, D Blum, E Lehtonen, L Abeloos, ...
Experimental neurology 204 (1), 387-399, 2007
|Use of an autonomous parvovirus vector for selective transfer of a foreign gene into transformed human cells of different tissue origins and its expression therein|
F Dupont, L Tenenbaum, LP Guo, P Spegelaere, M Zeicher, ...
Journal of virology 68 (3), 1397-1406, 1994
|Minocycline in phenotypic models of Huntington's disease|
K Bantubungi, C Jacquard, A Greco, A Pintor, A Chtarto, K Tai, MC Galas, ...
Neurobiology of disease 18 (1), 206-217, 2005
|A system for detection of genetic and epigenetic alterations in Escherichia coli induced by DNA-damaging agents|
Z Toman, C Dambly-Chaudiere, L Tenenbaum, M Radman
Journal of molecular biology 186 (1), 97-105, 1985
|Glial cell line-derived neurotrophic factor gene delivery in Parkinson's disease: a delicate balance between neuroprotection, trophic effects, and unwanted compensatory mechanisms|
L Tenenbaum, M Humbert-Claude
Frontiers in neuroanatomy 11, 29, 2017
|GDNF, a neuron-derived factor upregulated in glial cells during disease|
M Duarte Azevedo, S Sander, L Tenenbaum
Journal of clinical medicine 9 (2), 456, 2020
|Tropism of AAV-2 vectors for neurons of the globus pallidus|
L Tenenbaum, F Jurysta, A Stathopoulos, Z Puschban, C Melas, ...
Neuroreport 11 (10), 2277-2283, 2000
|Reversible neurochemical changes mediated by delayed intrastriatal glial cell line‐derived neurotrophic factor gene delivery in a partial Parkinson's disease rat model|
X Yang, B Mertens, E Lehtonen, L Vercammen, O Bockstael, A Chtarto, ...
The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2009
|A next step in adeno‐associated virus‐mediated gene therapy for neurological diseases: Regulation and targeting|
A Chtarto, O Bockstael, T Tshibangu, O Dewitte, M Levivier, L Tenenbaum
British journal of clinical pharmacology 76 (2), 217-232, 2013